Can a Dating App Run a Pharmacy? Grindr Is Betting $250M on It.

For 17 years, the answer to “What does a dating app buy when it has money to spend?” was “nothing.” But on September 30, Grindr announced a $250 million deal for PurposeMed, parent company of Freddie, a telehealth clinic that prescribes and sends out the daily pill PrEP, which reduces a person’s risk of HIV by about 99%.

This is Grindr’s first major acquisition since it was founded in 2009. And it’s not another dating app. It’s a pharmacy with a waiting room. And here’s what CEO George Arison told CNBC about it: “Now we have the next business line that we believe will be as profitable as the core business, and the same size, if not bigger, than what the core business is today.”

I’ve heard many of the big players in this space talk about a “second act” for their platforms, beyond ads and subscriptions. Bumble hints at a product for friends. Tinder is constantly hosting events in the real world. And Match Group put $100 million into Sniffies.

But for the first time, one of them has actually acquired another business with its own margin and revenue potential. And they told investors how big they think it could become.

What Grindr Actually Bought

In this deal, Grindr is paying $190 million in cash and $60 million in stock, plus up to $70 million in cash if Freddie meets performance targets in 2027. Assuming standard closing conditions, this should close in Q4.

What exactly is in this deal? Freddie started in Canada in 2020, expanded to the U.S. in 2024, and now serves patients in all 50 states and D.C. To date, it has treated over 55,000 patients in the U.S. and Canada.

Grindr says Freddie will generate over $80 million in revenue this year and over $10 million in adjusted EBITDA.

But it's not the revenue that excites me. It's the plumbing. In Grindr's press release, Freddie is described as having a physician-led team, telehealth capabilities, testing relationships, pharmacy operations, patient-support infrastructure, and experience operating in a regulated health care environment.

Woodwork, the erectile dysfunction brand launched by Grindr in May 2025, was only a front end. It used third-party clinicians from a company called OpenLoop. And as Sherwood News noted at the time, it didn't itself have pharmacists or doctors. It built the interface and the branding and rented the rest.

Freddie fills that space. Arison said Grindr could have done all of this internally, but it would have taken two or three years to get to this scale.

"You need to build out pharmacies, and you need to have clinicians to be able to fulfill the care that you're providing people," he told CNBC. "As you get more patients, then utilization improves, and then you're in a very high margin profile." Put another way, Grindr paid $250 million to skip the line rather than building this in-house.

Why This Math Works for Grindr and Almost Nobody Else

If I were responsible for product strategy at Bumble or Match Group, I'd ask: do I have enough users with a particular need on my app that it would make sense for me to fulfill that need myself, rather than sending them elsewhere?

Grindr says, emphatically, yes. And here's why. Grindr has about 16 million monthly active users. About 400,000 of its U.S. users identify on their profile that they use PrEP. Today, 650,000 Americans use PrEP. But as many as 2.2 million could. And use among gay and bisexual men is increasing by roughly 10% each year. That gap represents Grindr's opportunity. And every day, those users open up its app.

Arison told CNBC the combined pharmacy and telehealth business would bring in more than $400 a month per active patient and more than $4,800 a year for someone who stays in care. Multiply that by 50,000 patients in the U.S. and he's talking about roughly $240 million a year in revenue for the business. Grindr itself has margins of over 40%. He believes at scale its health business could approach that margin, but in the near term the development of its U.S. operation would drag on its margins.

But what would a typical user of a general dating app need in a service so important and so consistent that the app should build a pharmacy and telehealth business around it? I can't think of one. Maybe therapy. Maybe fertility. But neither of these would appear in a profile field of 400,000 people in the app.

And that's the uncomfortable truth for other players in this space. An "everything" app only works if your audience is dense enough around a single need. And Grindr's is. But the audiences of the general-interest apps out there aren't.

Hims, Ro, and the Problem of Free Distribution

And the second set of people who should be paying attention to this deal isn't in the dating space. Every day, telehealth brands spend big money to reach patients. Grindr doesn't need to do that. It could add a button for Grindr Health in its app in front of 16 million users for the cost of a push notification.

And Arison has said he wants users to be able, through this button, to find out about PrEP, check their insurance, connect with a clinician, get tested, get a prescription, and pick up refills without ever leaving the app. That's a different kind of competitor than a legacy pharmacy chain.

Hims & Hers and Ro have built very effective marketing engines. And in fact, Hims has advertised on Grindr's more risqué cousin, Sniffies, according to Sherwood News. But that's not the same as being the community. And a dating app that, for gay men, becomes the gateway to sexual health could well have more value than a Super Bowl ad.

Will either incumbent hedge? I'd watch for it.

The Street Wanted This, and Arison Knows It

For about a year, Grindr has told its investors it wanted to do more than just dating. Connie Loizos of TechCrunch reported in August that the stock was trading at a roughly 35% discount to its peers even though it was profitable. And Arison's response was the "gayborhood in your pocket" argument: dating, health care, and eventually travel, all in one app.

In July, Morgan Stanley bought into that argument. It upgraded the stock, pointing to Grindr's push into telehealth.

"We're doing exactly what we promised the street," said Arison on CNBC. "I hope people view us as a platform company that is not just an online business, but rather multiple lines of business with a community that really cares about this product, and we care about them."

For a decade, the dating industry has argued its users are a community, not a database. And now, with $250 million, Grindr is betting that community will also let the app be its doctor.

To the platforms out there: the next important earnings call in this industry won't be about swiping. It will be about patients.